News & Trends - MedTech & Diagnostics
Philips’ game-changing imaging technology increases operational efficiency
MedTech News: Pindara Private Hospital has turned an unloved operating theatre into an in-demand surgery option thanks to “game-changing” new imaging technology that gives Gold Coast patients more treatment options.
It is the first hospital in QLD to invest in a ceiling-mounted FlexArm system, which allows specialist teams to perform real-time imaging in 2D and 3D without needing to move the patient or operating table.
The Philips Azurion7 C20 lets Pindara’s medical teams move freely around their patients, and perform multiple surgeries or procedures at once.
It is installed in a hybrid theatre previously unpopular with some surgeons due to its space limitations.
Director of clinical services Tracey Clark said the technology was already proving to be a game-changer for the hospital and patients in the region, who can now access a wider range of procedures including chemotherapy to treat liver cancer, vascular and other interventions, orthopaedics and neurosurgery.
“It has been a fantastic investment for us and our medical specialists have been very positive about it.
“It’s placed in our Theatre 11 Hybrid Room and while we used to have surgeons who didn’t want to work in there because of its space limitations, these surgeons are now asking to use that room because of this amazing technology.
“It provides very high-definition imaging and the quality is first class. It really has made a big difference to the type of imaging we can obtain,” Ms Clark said.
News & Trends - MedTech & Diagnostics
Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ
The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]
MoreNews & Trends - Biotechnology
AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future
AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]
MoreNews & Trends - Pharmaceuticals
Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study
Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]
More